Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).
暂无分享，去创建一个
D. Schadendorf | C. Horak | R. Dummer | J. Wolchok | J. Larkin | F. Hodi | M. Smylie | P. Rutkowski | J. Grob | V. Chiarion-Sileni | G. McArthur | R. Gonzalez | J. Haanen | M. Maio | C. Lao | J. Larkin | P. Ferrucci | A. Hill | D. Walker | C. L. Cowey | Joel Jiang | C. Cowey